191 related articles for article (PubMed ID: 36125843)
41. Anticancer copper(II) phosphorus dendrimers are potent proapoptotic Bax activators.
Mignani S; El Brahmi N; Eloy L; Poupon J; Nicolas V; Steinmetz A; El Kazzouli S; Bousmina MM; Blanchard-Desce M; Caminade AM; Majoral JP; Cresteil T
Eur J Med Chem; 2017 May; 132():142-156. PubMed ID: 28350998
[TBL] [Abstract][Full Text] [Related]
42. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
[TBL] [Abstract][Full Text] [Related]
43. Polymeric indoximod based prodrug nanoparticles with doxorubicin entrapment for inducing immunogenic cell death and improving the immunotherapy of breast cancer.
Zang X; Song J; Yi X; Piyu J
J Mater Chem B; 2022 Mar; 10(12):2019-2027. PubMed ID: 35254372
[TBL] [Abstract][Full Text] [Related]
44. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
Yang M; Li J; Gu P; Fan X
Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
[TBL] [Abstract][Full Text] [Related]
45. Orchestrating Precision within the Tumor Microenvironment by Biomimetic Nanoprodrugs for Effective Tumor Therapy.
Wang Y; Xu H; Huang X; Zhang Y; Lu Y; Cheng J; Xu X; Li J; Yao H; Chen X
ACS Appl Mater Interfaces; 2024 Feb; 16(7):8484-8498. PubMed ID: 38334265
[TBL] [Abstract][Full Text] [Related]
46. A Homotypic Membrane-Camouflaged Biomimetic Nanoplatform with Gold Nanocrystals for Synergistic Photothermal/Starvation/Immunotherapy.
Li Z; Rong L
ACS Appl Mater Interfaces; 2021 May; 13(20):23469-23480. PubMed ID: 33999610
[TBL] [Abstract][Full Text] [Related]
47. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release.
Lin CW; Lu KY; Wang SY; Sung HW; Mi FL
Acta Biomater; 2016 Apr; 35():280-92. PubMed ID: 26853764
[TBL] [Abstract][Full Text] [Related]
48. Bio-Responsive nanoparticle for tumor targeting and enhanced photo-immunotherapy.
Tian D; Qin F; Zhao H; Zhang C; Wang H; Liu N; Ai Y
Colloids Surf B Biointerfaces; 2021 Jun; 202():111681. PubMed ID: 33714187
[TBL] [Abstract][Full Text] [Related]
49. Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD-L1 for Enhanced Cancer Immunotherapy.
Guo B; Yang F; Zhang L; Zhao Q; Wang W; Yin L; Chen D; Wang M; Han S; Xiao H; Xing N
Adv Mater; 2023 Jun; 35(22):e2212267. PubMed ID: 36916030
[TBL] [Abstract][Full Text] [Related]
50. Nanoparticle-mediated celastrol ER targeting delivery amplify immunogenic cell death in melanoma.
Wang F; Lai W; Xie D; Zhou M; Wang J; Xu R; Zhang R; Li G
J Adv Res; 2024 Jun; ():. PubMed ID: 38897272
[TBL] [Abstract][Full Text] [Related]
51. Prodrug-Based Versatile Nanomedicine for Enhancing Cancer Immunotherapy by Increasing Immunogenic Cell Death.
Bai S; Yang LL; Wang Y; Zhang T; Fu L; Yang S; Wan S; Wang S; Jia D; Li B; Xue P; Kang Y; Sun ZJ; Xu Z
Small; 2020 May; 16(19):e2000214. PubMed ID: 32309900
[TBL] [Abstract][Full Text] [Related]
52. Macrophage Membrane-Camouflaged Responsive Polymer Nanogels Enable Magnetic Resonance Imaging-Guided Chemotherapy/Chemodynamic Therapy of Orthotopic Glioma.
Xiao T; He M; Xu F; Fan Y; Jia B; Shen M; Wang H; Shi X
ACS Nano; 2021 Dec; 15(12):20377-20390. PubMed ID: 34860014
[TBL] [Abstract][Full Text] [Related]
53. Multifunctional Nanoparticles Boost Cancer Immunotherapy Based on Modulating the Immunosuppressive Tumor Microenvironment.
Li J; Zhao M; Sun M; Wu S; Zhang H; Dai Y; Wang D
ACS Appl Mater Interfaces; 2020 Nov; 12(45):50734-50747. PubMed ID: 33124808
[TBL] [Abstract][Full Text] [Related]
54. Tumor microenvironment-responsive Ag
Han R; Liu Q; Lu Y; Peng J; Pan M; Wang G; Chen W; Xiao Y; Yang C; Qian Z
Biomaterials; 2022 Feb; 281():121328. PubMed ID: 34953333
[TBL] [Abstract][Full Text] [Related]
55. Photothermal therapy mediated by phase-transformation nanoparticles facilitates delivery of anti-PD1 antibody and synergizes with antitumor immunotherapy for melanoma.
Zhang N; Song J; Liu Y; Liu M; Zhang L; Sheng D; Deng L; Yi H; Wu M; Zheng Y; Wang Z; Yang Z
J Control Release; 2019 Jul; 306():15-28. PubMed ID: 31132380
[TBL] [Abstract][Full Text] [Related]
56. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
[TBL] [Abstract][Full Text] [Related]
57. Reprogramming Tumor Immune Microenvironment (TIME) and Metabolism via Biomimetic Targeting Codelivery of Shikonin/JQ1.
Wang H; Tang Y; Fang Y; Zhang M; Wang H; He Z; Wang B; Xu Q; Huang Y
Nano Lett; 2019 May; 19(5):2935-2944. PubMed ID: 30950276
[TBL] [Abstract][Full Text] [Related]
58. Biodegradable Copper-Based Nanoparticles Augmented Chemodynamic Therapy through Deep Penetration and Suppressing Antioxidant Activity in Tumors.
Zheng R; Cheng Y; Qi F; Wu Y; Han X; Yan J; Zhang H
Adv Healthc Mater; 2021 Jul; 10(14):e2100412. PubMed ID: 34075731
[TBL] [Abstract][Full Text] [Related]
59. Polymeric Nanomedicine for Combined Gene/Chemotherapy Elicits Enhanced Tumor Suppression.
Xu B; Xia S; Wang F; Jin Q; Yu T; He L; Chen Y; Liu Y; Li S; Tan X; Ren K; Yao S; Zeng J; Song X
Mol Pharm; 2016 Feb; 13(2):663-76. PubMed ID: 26695934
[TBL] [Abstract][Full Text] [Related]
60. Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer's disease mice.
Gao C; Wang Y; Sun J; Han Y; Gong W; Li Y; Feng Y; Wang H; Yang M; Li Z; Yang Y; Gao C
Acta Biomater; 2020 May; 108():285-299. PubMed ID: 32251785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]